BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huong PT, Nguyen LT, Nguyen XB, Lee SK, Bach DH. The Role of Platelets in the Tumor-Microenvironment and the Drug Resistance of Cancer Cells. Cancers (Basel) 2019;11:E240. [PMID: 30791448 DOI: 10.3390/cancers11020240] [Cited by in Crossref: 42] [Cited by in F6Publishing: 38] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Saha B, Mathur T, Tronolone JJ, Chokshi M, Lokhande GK, Selahi A, Gaharwar AK, Afshar-Kharghan V, Sood AK, Bao G, Jain A. Human tumor microenvironment chip evaluates the consequences of platelet extravasation and combinatorial antitumor-antiplatelet therapy in ovarian cancer. Sci Adv 2021;7:eabg5283. [PMID: 34290095 DOI: 10.1126/sciadv.abg5283] [Reference Citation Analysis]
2 Han SN, Feng SJ, Liu Y. Prognostic and clinicopathological significance of the platelet-to-lymphocyte ratio in melanoma: A meta-analysis involving 2099 patients. Kaohsiung J Med Sci 2021;37:55-62. [PMID: 32783332 DOI: 10.1002/kjm2.12290] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Phung CD, Pham TT, Nguyen HT, Nguyen TT, Ou W, Jeong JH, Choi HG, Ku SK, Yong CS, Kim JO. Anti-CTLA-4 antibody-functionalized dendritic cell-derived exosomes targeting tumor-draining lymph nodes for effective induction of antitumor T-cell responses. Acta Biomater 2020;115:371-82. [PMID: 32798721 DOI: 10.1016/j.actbio.2020.08.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
4 Bisceglia I, Canale ML, Lestuzzi C, Parrini I, Russo G, Colivicchi F, Gabrielli D, Gulizia MM, Iliescu CA; on the behalf of ANMCO Cardio-Oncology Task Force. Acute coronary syndromes in cancer patients. J Cardiovasc Med (Hagerstown) 2020;21:944-52. [PMID: 32520859 DOI: 10.2459/JCM.0000000000000993] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Wang Q, Wei J, Shi Y. Platelet microvesicles promote the recovery of neurological function in mouse model of cerebral infarction by inducing angiogenesis. Biochem Biophys Res Commun 2019;513:997-1004. [PMID: 31005253 DOI: 10.1016/j.bbrc.2019.04.083] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yang W, Chen YY, Bi C, Shu KY, Ye ML, Li FF, Chen J, Wang XO, Chen XJ, Jiang MH. Predictive and prognostic values of preoperative platelet parameters in patients with gynecological tumors. J Clin Lab Anal 2020;34:e23295. [PMID: 32170805 DOI: 10.1002/jcla.23295] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Lee EHC, Wong DCP, Ding JL. NK Cells in a Tug-of-War With Cancer: The Roles of Transcription Factors and Cytoskeleton. Front Immunol 2021;12:734551. [PMID: 34594338 DOI: 10.3389/fimmu.2021.734551] [Reference Citation Analysis]
8 Sier VQ, de Vries MR, van der Vorst JR, Vahrmeijer AL, van Kooten C, Cruz LJ, de Geus-Oei LF, Ferreira V, Sier CFM, Alves F, Muthana M. Cell-Based Tracers as Trojan Horses for Image-Guided Surgery. Int J Mol Sci 2021;22:E755. [PMID: 33451116 DOI: 10.3390/ijms22020755] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Campanella R, Guarnaccia L, Cordiglieri C, Trombetta E, Caroli M, Carrabba G, La Verde N, Rampini P, Gaudino C, Costa A, Luzzi S, Mantovani G, Locatelli M, Riboni L, Navone SE, Marfia G. Tumor-Educated Platelets and Angiogenesis in Glioblastoma: Another Brick in the Wall for Novel Prognostic and Targetable Biomarkers, Changing the Vision from a Localized Tumor to a Systemic Pathology. Cells 2020;9:E294. [PMID: 31991805 DOI: 10.3390/cells9020294] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
10 Nie Z, Zhao P, Shang Y, Sun B. Nomograms to predict the prognosis in locally advanced oral squamous cell carcinoma after curative resection. BMC Cancer 2021;21:372. [PMID: 33827452 DOI: 10.1186/s12885-021-08106-x] [Reference Citation Analysis]
11 Geranpayehvaghei M, Dabirmanesh B, Khaledi M, Atabakhshi-Kashi M, Gao C, Taleb M, Zhang Y, Khajeh K, Nie G. Cancer-associated-platelet-inspired nanomedicines for cancer therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;13:e1702. [PMID: 33538125 DOI: 10.1002/wnan.1702] [Reference Citation Analysis]
12 Goswami C, Chawla S, Thakral D, Pant H, Verma P, Malik PS, Jayadeva, Gupta R, Ahuja G, Sengupta D. Molecular signature comprising 11 platelet-genes enables accurate blood-based diagnosis of NSCLC. BMC Genomics 2020;21:744. [PMID: 33287695 DOI: 10.1186/s12864-020-07147-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
13 Thanh Huong P, Gurshaney S, Thanh Binh N, Gia Pham A, Hoang Nguyen H, Thanh Nguyen X, Pham-The H, Tran PT, Truong Vu K, Xuan Duong N, Pelucchi C, La Vecchia C, Boffetta P, Nguyen HD, Luu HN. Emerging Role of Circulating Tumor Cells in Gastric Cancer. Cancers (Basel) 2020;12:E695. [PMID: 32183503 DOI: 10.3390/cancers12030695] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
14 Hu L, Zhang P, Mei Q, Sun W, Zhou L, Yin T. Podoplanin is a useful prognostic marker and indicates better differentiation in lung squamous cell cancer patients? A systematic review and meta-analysis. BMC Cancer 2020;20:424. [PMID: 32408907 DOI: 10.1186/s12885-020-06936-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Hussain Y, Abdullah, Alsharif KF, Aschner M, Theyab A, Khan F, Saso L, Khan H. Therapeutic Role of Carotenoids in Blood Cancer: Mechanistic Insights and Therapeutic Potential. Nutrients 2022;14:1949. [DOI: 10.3390/nu14091949] [Reference Citation Analysis]
16 Bokas A, Papakotoulas P, Sarantis P, Papadimitropoulou A, Papavassiliou AG, Karamouzis MV. Mechanisms of the Antitumor Activity of Low Molecular Weight Heparins in Pancreatic Adenocarcinomas. Cancers (Basel) 2020;12:E432. [PMID: 32069809 DOI: 10.3390/cancers12020432] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
17 Wu YY, Chang KP, Ho TY, Chou WC, Hung SP, Fan KH, Chiang YY, Chou YC, Tsang NM. Comparative prognostic value of different preoperative complete blood count cell ratios in patients with oral cavity cancer treated with surgery and postoperative radiotherapy. Cancer Med 2021;10:1975-88. [PMID: 33624454 DOI: 10.1002/cam4.3738] [Reference Citation Analysis]
18 Faria AVS, Yu B, Mommersteeg M, de Souza-Oliveira PF, Andrade SS, Spaander MCW, de Maat MPM, Peppelenbosch MP, Ferreira-Halder CV, Fuhler GM. Platelet-dependent signaling and Low Molecular Weight Protein Tyrosine Phosphatase expression promote aggressive phenotypic changes in gastrointestinal cancer cells. Biochim Biophys Acta Mol Basis Dis 2022;1868:166280. [PMID: 34610471 DOI: 10.1016/j.bbadis.2021.166280] [Reference Citation Analysis]
19 Hu L, Zhang P, Sun W, Zhou L, Chu Q, Chen Y. PDPN is a prognostic biomarker and correlated with immune infiltrating in gastric cancer. Medicine (Baltimore) 2020;99:e19957. [PMID: 32384443 DOI: 10.1097/MD.0000000000019957] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
20 Miao Y, Xu Z, Feng W, Zheng M, Xu Z, Gao H, Li W, Zhang Y, Zong Y, Lu A, Zhao J. Platelet infiltration predicts survival in postsurgical colorectal cancer patients. Int J Cancer 2021. [PMID: 34551136 DOI: 10.1002/ijc.33816] [Reference Citation Analysis]
21 Zimmer N, Krebs FK, Zimmer S, Mitzel-Rink H, Kumm EJ, Jurk K, Grabbe S, Loquai C, Tuettenberg A. Platelet-Derived GARP Induces Peripheral Regulatory T Cells-Potential Impact on T Cell Suppression in Patients with Melanoma-Associated Thrombocytosis. Cancers (Basel) 2020;12:E3653. [PMID: 33291452 DOI: 10.3390/cancers12123653] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Bach DH, Zhang W, Sood AK. Chromosomal Instability in Tumor Initiation and Development. Cancer Res 2019;79:3995-4002. [PMID: 31350294 DOI: 10.1158/0008-5472.CAN-18-3235] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
23 Casagrande N, Borghese C, Agostini F, Durante C, Mazzucato M, Colombatti A, Aldinucci D. In Ovarian Cancer Multicellular Spheroids, Platelet Releasate Promotes Growth, Expansion of ALDH+ and CD133+ Cancer Stem Cells, and Protection against the Cytotoxic Effects of Cisplatin, Carboplatin and Paclitaxel. Int J Mol Sci 2021;22:3019. [PMID: 33809553 DOI: 10.3390/ijms22063019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
24 Pavlovic N, Rani B, Gerwins P, Heindryckx F. Platelets as Key Factors in Hepatocellular Carcinoma. Cancers (Basel) 2019;11:E1022. [PMID: 31330817 DOI: 10.3390/cancers11071022] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
25 Yin JB, Li N, Cui MM, Wang X, Wang RT. Reduced mean platelet volume levels predict shorter survival in patients with resectable pancreatic ductal adenocarcinoma and type 2 diabetes. BMC Gastroenterol 2020;20:143. [PMID: 32393273 DOI: 10.1186/s12876-020-01225-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Ali S, Borin TF, Piranlioglu R, Ara R, Lebedyeva I, Angara K, Achyut BR, Arbab AS, Rashid MH. Changes in the tumor microenvironment and outcome for TME-targeting therapy in glioblastoma: A pilot study. PLoS One 2021;16:e0246646. [PMID: 33544755 DOI: 10.1371/journal.pone.0246646] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Monteiro CF, Custódio CA, Mano JF. Bioengineering a humanized 3D tri-culture osteosarcoma model to assess tumor invasiveness and therapy response. Acta Biomater 2021:S1742-7061(21)00472-4. [PMID: 34303015 DOI: 10.1016/j.actbio.2021.07.034] [Reference Citation Analysis]
28 Yekedüz E, Dogan İ, Kaya DM, Özgür İ, Utkan G, Vatansever S, Demirci S, Akbulut H, Ürün Y. Systemic Immune-Inflammation Index as a Prognostic Marker of Late Recurrence in Operable Gastric Cancer: a Dual-Center Study. J Gastrointest Cancer 2021. [PMID: 34845631 DOI: 10.1007/s12029-021-00769-w] [Reference Citation Analysis]
29 Bellefeuille SD, Molle CM, Gendron FP. Reviewing the role of P2Y receptors in specific gastrointestinal cancers. Purinergic Signal 2019;15:451-63. [PMID: 31478181 DOI: 10.1007/s11302-019-09678-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
30 Streubel G, Schrepfer S, Kallus H, Parnitzke U, Wulff T, Hermann F, Borgmann M, Hamm S. Histone deacetylase inhibitor resminostat in combination with sorafenib counteracts platelet-mediated pro-tumoral effects in hepatocellular carcinoma. Sci Rep 2021;11:9587. [PMID: 33953226 DOI: 10.1038/s41598-021-88983-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Belayneh YM, Amare GG, Meharie BG. Updates on the molecular mechanisms of aspirin in the prevention of colorectal cancer: Review. J Oncol Pharm Pract 2021;27:954-61. [PMID: 33427041 DOI: 10.1177/1078155220984846] [Reference Citation Analysis]
32 Chen Y, Yang W, Ye L, Lin S, Shu K, Yang X, Ai X, Yao Y, Jiang M. Economical and easily detectable markers of digestive tumors: platelet parameters. Biomark Med 2021;15:157-66. [PMID: 33474972 DOI: 10.2217/bmm-2020-0203] [Reference Citation Analysis]
33 Şahin AB, Cubukcu E, Ocak B, Deligonul A, Oyucu Orhan S, Tolunay S, Gokgoz MS, Cetintas S, Yarbas G, Senol K, Goktug MR, Yanasma ZB, Hasanzade U, Evrensel T. Low pan-immune-inflammation-value predicts better chemotherapy response and survival in breast cancer patients treated with neoadjuvant chemotherapy. Sci Rep 2021;11:14662. [PMID: 34282214 DOI: 10.1038/s41598-021-94184-7] [Reference Citation Analysis]
34 Sturtz LA, Wang G, Shah P, Searfoss R, Raj-Kumar PK, Hooke JA, Fantacone-Campbell JL, Deyarmin B, Cutler ML, Sarangarajan R, Narain NR, Hu H, Kiebish MA, Kovatich AJ, Shriver CD. Comparative analysis of differentially abundant proteins quantified by LC-MS/MS between flash frozen and laser microdissected OCT-embedded breast tumor samples. Clin Proteomics 2020;17:40. [PMID: 33292179 DOI: 10.1186/s12014-020-09300-y] [Reference Citation Analysis]
35 Qu CH, Li T, Tang ZP, Zhu XR, Han JY, Tian H. Platelet Count is Associated with the Rate of Lymph Node Metastasis in Lung Adenocarcinoma. Cancer Manag Res 2020;12:9765-74. [PMID: 33116836 DOI: 10.2147/CMAR.S273328] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
36 D'Ambrosi S, Nilsson RJ, Wurdinger T. Platelets and tumor-associated RNA transfer. Blood 2021;137:3181-91. [PMID: 33940602 DOI: 10.1182/blood.2019003978] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Luzo ACM, Fávaro WJ, Seabra AB, Durán N. What is the potential use of platelet-rich-plasma (PRP) in cancer treatment? A mini review. Heliyon 2020;6:e03660. [PMID: 32258495 DOI: 10.1016/j.heliyon.2020.e03660] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
38 Marx S, Xiao Y, Baschin M, Splittstöhser M, Altmann R, Moritz E, Jedlitschky G, Bien-Möller S, Schroeder HWS, Rauch BH. The Role of Platelets in Cancer Pathophysiology: Focus on Malignant Glioma. Cancers (Basel) 2019;11:E569. [PMID: 31013620 DOI: 10.3390/cancers11040569] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
39 Geranpayehvaghei M, Shi Q, Zhao B, Li S, Xu J, Taleb M, Qin H, Zhang Y, Khajeh K, Nie G. Targeting Delivery of Platelets Inhibitor to Prevent Tumor Metastasis. Bioconjug Chem 2019;30:2349-57. [PMID: 31429535 DOI: 10.1021/acs.bioconjchem.9b00457] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
40 Nazari M, Javandoost E, Talebi M, Movassaghpour A, Soleimani M. Platelet Microparticle Controversial Role in Cancer. Adv Pharm Bull 2021;11:39-55. [PMID: 33747851 DOI: 10.34172/apb.2021.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
41 Ye T, Wan X, Li J, Feng J, Guo J, Li G, Liu J. The Clinical Significance of PPEF1 as a Promising Biomarker and Its Potential Mechanism in Breast Cancer. Onco Targets Ther 2020;13:199-214. [PMID: 32021267 DOI: 10.2147/OTT.S229432] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Dovizio M, Ballerini P, Fullone R, Tacconelli S, Contursi A, Patrignani P. Multifaceted Functions of Platelets in Cancer: From Tumorigenesis to Liquid Biopsy Tool and Drug Delivery System. Int J Mol Sci 2020;21:E9585. [PMID: 33339204 DOI: 10.3390/ijms21249585] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
43 Wilson RB, Archid R, Reymond MA. Reprogramming of Mesothelial-Mesenchymal Transition in Chronic Peritoneal Diseases by Estrogen Receptor Modulation and TGF-β1 Inhibition. Int J Mol Sci 2020;21:E4158. [PMID: 32532126 DOI: 10.3390/ijms21114158] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
44 Jackson JW, Rivera-Marquez GM, Beebe K, Tran AD, Trepel JB, Gestwicki JE, Blagg BSJ, Ohkubo S, Neckers LM. Pharmacologic dissection of the overlapping impact of heat shock protein family members on platelet function. J Thromb Haemost 2020;18:1197-209. [PMID: 32022992 DOI: 10.1111/jth.14758] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
45 Mirkhani N, Gwisai T, Schuerle S. Engineering Cell‐Based Systems for Smart Cancer Therapy. Advanced Intelligent Systems 2022;4:2100134. [DOI: 10.1002/aisy.202100134] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Morrone FB, Vargas P, Rockenbach L, Scheffel TB. P2Y12 Purinergic Receptor and Brain Tumors: Implications on Glioma Microenvironment. Molecules 2021;26:6146. [PMID: 34684726 DOI: 10.3390/molecules26206146] [Reference Citation Analysis]
47 Nakao S, Minaguchi T, Itagaki H, Hosokawa Y, Shikama A, Tasaka N, Akiyama A, Ochi H, Matsumoto K, Satoh T. Pretreatment thrombocytosis as an independent predictive factor for chemoresistance and poor survival in epithelial ovarian cancer. J Ovarian Res 2020;13:55. [PMID: 32375852 DOI: 10.1186/s13048-020-00651-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]